Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 339 results for "srl diagnostics"

SRL Diagnostics may see exit of PE investors Avigo Capital, Ja...

MUMBAI:Private equity investors Avigo Capital, Jacob Ballas and IFC are likely to exit SRL Diagnostics, a subsidiary of hospital chain Fortis Healthcare promoted by Malvinder and Shivinder Singh, the former owners of Ranbaxy, two people familiar ... Economic Times, 5 hours ago

66.11% of Indian children exhibit abnormal level of sugar in thei...

New Delhi, Nov 13 (IBNS): SRL Diagnostics recently released a three year long pan India data mining survey (2012 2014) on Hba1C tests that revealed that around 66.11 % Indian children possess abnormal levels of sugar in their body. This test is ...
 India Blooms1 week ago 66.11 per cent Indian children exhibit abnormal sugar levels in their body: SRL study  Financial Express1 week ago 66 per cent kids under 15 have pre-diabetes  Asian Age1 week ago World Diabetes Day: 66.11% Indian kids show abnormal sugar level in body, says study  DNA India1 week ago
Times of India

Fortis-owned SRL plans Rs 1,250-crore share sale

MUMBAI: India's largest pathology chain SRL Diagnostics, majority owned by Fortis Healthcare, has started a large stake sale process attracting interest from sovereign wealth funds and bulge-bracket private equity firms. SRL has roped in investment ...
 Times of India1 month ago Fortis to buy back 3.1% stake in SRL Ltd for Rs 105 cr  Hindu Business Line1 month ago Fortis is improving, but expensive valuations  Business Standard India1 month ago Fortis Healthcare: Improving health, but valuations expensive  Business Standard India1 month ago

Toscana Biomarkers Srl - Product Pipeline Analysis, 2015 Update

Toscana Biomarkers Srl (Toscana) is a research and development company that discovers, develops and validates diagnostic tests for autoimmune diseases. The company offers products such as antigenic probes for biomarkers identification and diagnostic ...
 Research and Markets3 weeks ago

Indian Kids Are Unhealthy With One In Three Children Vulnerable To Diabetes

A survey on diagnostic tests done across the country has revealed that one in three children in the under 15 age group are susceptible to becoming diabetic. Even Type 2 diabetes that reduces life expectancy has been detected among children. ...
 Indiatimes1 week ago One in three kids vulnerable to diabetes  Times of India1 week ago
VC Circle

Exclusive: LabStreet raises angel funding

Gurgaon-based, Kronica Medical Services Pvt Ltd which runs and operates, LabStreet , a demand aggregator for diagnostic labs, has raised Rs 1 crore ($150,000) in angel funding from multiple investors including Chandigarh-based Click Labs. The ...
 VC Circle2 months ago

ERBA to Launch LISA XL System in Europe and International Markets; Product to be Featured at MEDICA 2015

MIAMI, Nov. 15, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, will be introducing the new fully automated diagnostic testing instruments, the LISA XL ELISA Processor and Reader for ...
 SearchBug1 week ago Erba Diagnostics To Launch LISA XL System In Europe And International Markets; Product To Be Featured At  BioSpace1 week ago

Leukemia Pipeline Diagnostic Tests Review 2015

(Before It's News) Adds Leukemia Pipeline Review, 2015 which provides an overview of the Leukemia. The report provides comprehensive information on the pipeline products with comparative analysis of the products at ...
 Before It's News1 month ago Research and Markets: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Review, Development & Analysis Report 2015  Benzinga.com17 hours ago Research and Markets: Leukemia - Pipeline Review, 2015  Tamar Securities17 hours ago RESEARCH AND MARKETS : Leukemia - Pipeline Review, 2015  4 Traders17 hours ago

FDA 510(k) Application Withdrawn for Angiodroid CO2 Injector for Angiography

The decision to withdraw the 510(k) was unrelated to the Angiodroid Injector device but due to CO2 Angiodroid, Srl is a privately owned Italian entity. Angiodroid America, Inc., founded last year in affiliation with Triotech Ventures and ADMT, is ...
 Wall Street Select6 days ago Angiodroid yanks 510(k) over FDA CO2 clearance issue  MassDevice3 days ago ADM Tronics Withdraws FDA App for Angiodroid CO2 Injector for Angiography  BioSpace3 days ago ADMT withdraws Premarket Notification 510(k) application for Angiodroid Injector  News-Medical.Net4 days ago

Zacks Downgrades ERBA Diagnostics to Hold (ERB)

ERBA Diagnostics (NYSEMKT:ERB) was downgraded by Zacks from a buy rating to a hold rating in a report released on Wednesday, MarketBeat.Com reports. According to Zacks, ERBA Diagnostics, Inc. develops, manufactures and markets diagnostic test ...
 WKRB News1 month ago ERBA Diagnostics Downgraded by Zacks to Hold (ERB)  SleekMoney1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less